Urvashi Tyagi - Resmed Chief Officer

RSMDFDelisted Stock  USD 17.70  0.00  0.00%   

Insider

Urvashi Tyagi is Chief Officer of Resmed Inc DRC
Phone858 836 5000
Webhttps://www.resmed.com

Resmed Management Efficiency

The company has return on total asset (ROA) of 0.1155 % which means that it generated a profit of $0.1155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2352 %, meaning that it generated $0.2352 on every $100 dollars invested by stockholders. Resmed's management efficiency ratios could be used to measure how well Resmed manages its routine affairs as well as how well it operates its assets and liabilities.
Resmed Inc DRC has accumulated 765.33 M in total debt with debt to equity ratio (D/E) of 0.27, which may suggest the company is not taking enough advantage from borrowing. Resmed Inc DRC has a current ratio of 2.74, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Resmed until it has trouble settling it off, either with new capital or with free cash flow. So, Resmed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Resmed Inc DRC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Resmed to invest in growth at high rates of return. When we think about Resmed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

BE MBAResMed Inc
50
Teresa MaddenThe Cooper Companies,
65
Amy McbrideWendellBaxter International
60
Richard LuzziWest Pharmaceutical Services
72
Nicole PriestMerit Medical Systems
N/A
John KnorppMerit Medical Systems
N/A
Joseph PierceMerit Medical Systems
N/A
Candace MatthewsAptarGroup
61
James BorziBaxter International
61
Isabel MareySemperAptarGroup
53
Ajay KumarEmbecta Corp
53
Amy WakehamResMed Inc
N/A
Jacqueline KunzlerBaxter International
55
Warner HThe Cooper Companies,
56
Constance BienfaitResMed Inc
N/A
Neil PetersonMerit Medical Systems
57
Richard RosenzweigAngioDynamics
57
Justin LeongResMed Inc
47
Vered KeisarResMed Inc
N/A
Gerard IIIThe Cooper Companies,
59
A BenderThe Cooper Companies,
79
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. Resmed Inc operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 8160 people. Resmed Inc DRC [RSMDF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Resmed Inc DRC Leadership Team

Elected by the shareholders, the Resmed's board of directors comprises two types of representatives: Resmed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Resmed. The board's role is to monitor Resmed's management team and ensure that shareholders' interests are well served. Resmed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Resmed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amy Wakeham, VP Communications
Brett Sandercock, CFO and Principal Accounting Officer
BE MBA, CEO Director
Robert Douglas, Pres and COO
Vered Keisar, Chief Officer
David Pendarvis, Chief Admin. Officer, Global General Counsel and Secretary
AM AM, Founder Chairman
Kaushik Ghoshal, Pres Bus
Constance Bienfait, Director Relations
Urvashi Tyagi, Chief Officer

Resmed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Resmed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Resmed Pink Sheet

If you are still planning to invest in Resmed Inc DRC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Resmed's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Transaction History
View history of all your transactions and understand their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities